Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults
Clinical trial NCT00741637 · COMPLETED
Trial details
- NCT number
- NCT00741637
- Sponsor
- International Vaccine Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-04-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.